Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atricure Inc (NQ: ATRC )

35.94 +0.20 (+0.56%)
Streaming Delayed Price Updated: 10:44 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Atricure Inc

< Previous 1 2 3 Next >
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the Stifel 2024 Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Third Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the UBS Global Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
From AtriCure
Via Business Wire
AtriCure to Announce Third Quarter 2024 Financial Results
From AtriCure, Inc
Via Business Wire
AtriCure Receives CE-Mark for the EnCompass® Clamp
From AtriCure, Inc.
Via Business Wire
AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
From AtriCure, Inc.
Via Business Wire
AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Second Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce Second Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Reports First Quarter 2024 Financial Results
From AtriCure, Inc
Via Business Wire
AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce First Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024
From AtriCure, Inc.
Via Business Wire
AtriCure Appoints Shlomi Nachman to the Board of Directors
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From AtriCure
Via Business Wire
AtriCure to Participate in the Piper Sandler 35th Annual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Releases 2023 ESG Report
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Third Quarter 2023 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the Stifel 2023 Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce Third Quarter 2023 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Second Quarter 2023 Financial Results
From AtriCure, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.